Biovaccines Nigeria Limited has signed a partnership deal with Biofarma Indonesia Pharmaceuticalagency Manufacturing for the production of vaccines in the country.
The Chairman, Biovaccines Nigeria Limited, Oyewale Tomori, disclosed this during a courtesy visit of the Indonesian Ambassador, Usra Harahap, and his team to the company on Thursday in Lagos.
According to Tomori, the arrangement commenced after a conference in Indonesia and a visit to the country’s vaccine production setup, Biofarma pharmaceuticals in 2019.
“The visit of the Ambassador, I think, is a step in the right direction for us to concretise all our different arrangements.
“Because of the COVID-19, there is a slow down in activities and now the pandemic is gone, we are reviving the partnership”‘ Tomori said.
The virologist expressed optimism that the project will be successful, given the support and approval of the Federal Government and the Federal Executive Council.
“We hope that in another short time, and as soon as we get the necessary approvals from the government, things will move much faster than they have moved before. And then, sustaining that success will mean continuing the production of the vaccines and even extending to other things and I think we will get there as time goes on,” Tomori said.
On his part, the Chief Operating Officer, Biovaccines Nigeria Ltd., Everest Okeakpu, expressed hope that Nigeria will have graduated from the Global Alliance for Vaccines Initiative support which had been extended to 2028.
He said that the partnership will create huge employment opportunities for Nigerians, as well as conserve foreign exchange and enhance the capability of the country.